Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Transforming growth factors and receptor as potential modifiable pre-neoplastic biomarkers of risk for colorectal neoplasms.

Tu H, Ahearn TU, Daniel CR, Gonzalez-Feliciano AG, Seabrook ME, Bostick RM.

Mol Carcinog. 2015 Sep;54(9):821-30. doi: 10.1002/mc.22152. Epub 2014 Apr 9.

PMID:
24719252
2.

Effects of calcium and vitamin D3 on transforming growth factors in rectal mucosa of sporadic colorectal adenoma patients: a randomized controlled trial.

Tu H, Flanders WD, Ahearn TU, Daniel CR, Gonzalez-Feliciano AG, Long Q, Rutherford RE, Bostick RM.

Mol Carcinog. 2015 Apr;54(4):270-80. doi: 10.1002/mc.22096. Epub 2013 Oct 26.

3.

TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma.

Daniel CR, Bostick RM, Flanders WD, Long Q, Fedirko V, Sidelnikov E, Seabrook ME.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):65-73. doi: 10.1158/1055-9965.EPI-08-0732.

4.

Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms.

Sidelnikov E, Bostick RM, Flanders WD, Long Q, Seabrook ME.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2965-73. doi: 10.1158/1055-9965.EPI-09-0519. Epub 2009 Oct 27.

5.

MutL-homolog 1 expression and risk of incident, sporadic colorectal adenoma: search for prospective biomarkers of risk for colorectal cancer.

Sidelnikov E, Bostick RM, Flanders WD, Long Q, Cohen VL, Dash C, Seabrook ME, Fedirko V.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1599-609. doi: 10.1158/1055-9965.EPI-08-0800.

6.

Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms.

Ahearn TU, Shaukat A, Flanders WD, Seabrook ME, Bostick RM.

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):969-79. doi: 10.1158/1055-9965.EPI-12-0126. Epub 2012 Apr 26.

7.

Genetic variants at chromosome 8q24, colorectal epithelial cell proliferation, and risk for incident, sporadic colorectal adenomas.

Yang B, Thyagarajan B, Gross MD, Goodman M, Sun YV, Bostick RM.

Mol Carcinog. 2014 Feb;53 Suppl 1:E187-92. doi: 10.1002/mc.22047. Epub 2013 Jun 18.

PMID:
23776012
8.

Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis.

Logullo AF, Nonogaki S, Miguel RE, Kowalski LP, Nishimoto IN, Pasini FS, Federico MH, Brentani RR, Brentani MM.

J Oral Pathol Med. 2003 Mar;32(3):139-45.

PMID:
12581383
9.
10.
11.

Tissue localization of TGFalpha and apoptosis are inversely related in colorectal tumors.

Habel O, Bertario L, Andreola S, Sirizzotti G, Marian B.

Histochem Cell Biol. 2002 Mar;117(3):235-41. Epub 2002 Jan 22.

PMID:
11914921
12.

Transforming growth factor α immunoreactivity. A study in hepatocellular carcinoma and in non-neoplastic liver tissue.

Pannain VL, Morais JR, Damasceno-Ribeiro O, Avancini-Alves V.

Ann Hepatol. 2012 Jul-Aug;11(4):495-9.

13.

Changes of TGFbeta1 and TGFbetaRII expression in esophageal precancerous and cancerous lesions: a study of a high-risk population in Henan, northern China.

Zhou Q, Dong Wang L, Du F, Zhou Y, Rui Zhang Y, Liu B, Wei Feng C, Gao SS, Fan ZM, Yang CS, Zheng S.

Dis Esophagus. 2002;15(1):74-9.

PMID:
12060047
14.

FGF-2, TGFbeta-1, PDGF-A and respective receptors expression in pleomorphic adenoma myoepithelial cells: an in vivo and in vitro study.

Miguita L, Martinez EF, de Araújo NS, de Araújo VC.

J Appl Oral Sci. 2010 Jan-Feb;18(1):83-91.

15.

Transforming growth factor alpha distribution in rectal crypts as a biomarker of decreased colon cancer risk in patients consuming cellulose.

Hardman WE, Cameron IL, Beer WH, Speeg KV, Kadakia SC, Lang KA.

Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):633-7.

16.

Co-expression of EGF receptor, TGFalpha and S6 kinase is significantly associated with colorectal carcinomas with distant metastases at diagnosis.

Tampellini M, Longo M, Cappia S, Bacillo E, Alabiso I, Volante M, Dogliotti L, Papotti M.

Virchows Arch. 2007 Mar;450(3):321-8. Epub 2007 Jan 30.

PMID:
17265080
17.

EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma.

Messa C, Russo F, Caruso MG, Di Leo A.

Acta Oncol. 1998;37(3):285-9.

PMID:
9677101
18.
19.

A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients.

Ahearn TU, Shaukat A, Flanders WD, Rutherford RE, Bostick RM.

Cancer Prev Res (Phila). 2012 Oct;5(10):1247-56. doi: 10.1158/1940-6207.CAPR-12-0292. Epub 2012 Sep 10.

20.

Alcohol, cigarette smoking, dietary factors and the risk of colorectal adenomas and hyperplastic polyps--a case control study.

Erhardt JG, Kreichgauer HP, Meisner C, Bode JC, Bode C.

Eur J Nutr. 2002 Feb;41(1):35-43.

PMID:
11990006
Items per page

Supplemental Content

Write to the Help Desk